News: Molecular Biosciences

Molecular biosciences faculty contributed to advances that could lead to more effective, longer lasting vaccines.

Ken Keiler studies basic molecular biology with the aim of developing new antibiotics.

Interdisciplinary research teams involve UT Austin faculty in the life sciences, computer science and chemistry.

The OriGen Health Research Center will mine a massive biobank of genetic, clinical and epidemiological information to develop customized disease treatments.

Graduate students at The University of Texas at Austin have a new opportunity to revolutionize how medicines are developed and delivered.

Discovery brings us one step closer to vaccine and treatment for prevalent virus.

Matouschek, previously associate dean for research and facilities, will lead the College of Natural Sciences.

These non-living materials will have capabilities including self-healing, adaptation, growth and programmability.

A new study shows how plants balance growth and defense, offering insights for stronger, more resilient crops.

McLellan, who will be inducted in Washington, D.C. on May 8, is among the youngest new inductees in hall of fame history.